Detalhe da pesquisa
1.
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors.
Nat Cancer
; 1(9): 894-908, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121952